Myriad Genetics (MYGN) PT Lowered to $14 at Piper Sandler
Tweet
Share
E-mailGet Alerts MYGN Hot Sheet
Price: $4.54 +11.82%
Rating Summary:
6 Buy, 19 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 15 | New: 50
Rating Summary:
6 Buy, 19 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 15 | New: 50
Join SI Premium – FREE
Piper Sandler analyst William Quirk lowered the price target on Myriad Genetics (NASDAQ: MYGN) to $14.00 (from $20.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Myriad Genetics (MYGN) PT Raised to $8 at Craig-Hallum
- Siam Commercial Bank (SCB:TB) (SMUUY) PT Raised to THB150 at Macquarie
- Britannia Industries Ltd (BRIT:IN) PT Raised to INR5,100 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
